Marc Siegel

机构：George Washington University · ORCID：0000-0001-9029-8389

发表论文 112 篇 · 总被引 1301 次 · h-index 19

代表论文

• Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies (2024 · Clinical Infectious Diseases · 被引 22)
• Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial (2024 · Clinical Infectious Diseases · 被引 21)
• Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial (2024 · The Lancet HIV · 被引 12)
• Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data (2025 · JAMA Network Open · 被引 6)
• Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial (2025 · The Lancet HIV · 被引 6)
• HIV-1 latency reversal and immune enhancing activity of IL-15 is not influenced by sex hormones (2024 · JCI Insight · 被引 6)